The variant affects gene CAD (carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase), which is on Chromosome 2. Please evaluate whether this mutation is benign or pathogenic and specify the disease if necessary.
Pathogenic; Developmental and epileptic encephalopathy, 50